Oura files for a US IPO, reporting a $924.3M net loss on $1.21B in revenue for the nine months ended June 30, vs. a $182.8M net loss on $697.6M a year earlier
Health and fitness ring-maker Oura Inc. filed for an initial public offering, showing soaring revenue as well as increasing losses.
Context & Ripple Effects
Oura’s public registration follows its confidential IPO filing in May and a 2025 Series E that valued the company at $10.9 billion. Reports in August described a possible offering that could seek up to $3 billion and value Oura above $16 billion, though those terms were unconfirmed.
The filing turns that private-market narrative into a public financial test: revenue rose sharply year over year, while the reported net loss expanded far faster. That trade-off is central to how prospective shareholders will assess Oura’s growth model.
First-order effects
- Prospective public investors gain a detailed basis to price Oura, with $1.21 billion in nine-month revenue set against a $924.3 million net loss.
- Oura and its backers shift from the $10.9 billion private valuation established in the 2025 Series E toward a valuation determined through the IPO process.
Second-order effects
- The widening loss makes Oura’s ability to translate revenue growth into improving economics a central issue for prospective IPO buyers, rather than allowing topline growth to stand alone.
- The disclosed results provide a concrete benchmark against the previously reported, but unconfirmed, $3 billion IPO and $16 billion-plus valuation ambitions.
Third-order effects
- If public investors continue to reward wearable-device growth despite large losses, smart-ring companies may gain a clearer route from venture financing to public-market capital; if they do not, profitability will become a sharper gate for the category.
The trend: Oura’s filing is part of the broader shift in which consumer health-device makers must convert private-market growth narratives into public-market evidence of durable economics.